Kartesia
A pan-European private debt manager, now majority-owned by New York Life Investments and Candriam, specialising in lower-mid-market corporate lending across the capital structure.
What they do
Kartesia is a privately founded (2013), pan-European private debt manager running roughly €7.5bn across four complementary strategies: Senior Direct Lending (KSO), Opportunistic/Credit Opportunities (KCO), an Article 9 Impact fund (KIF), and Structured Credit (CLOs). It lends to European lower-mid-market companies — typically enterprise values around €30–250m, including the sub-€10m EBITDA cohort that banks increasingly underserve. KSO provides 100% first-lien senior secured loans, including unitranche packages for acquisition and growth financing; KCO is flexible across the capital structure and into special situations, originating both sponsored and off-market sponsorless deals. The firm describes its model as sitting between banks and private equity — more leverage than a bank, typically less dilutive than equity.
Where they fit in a lower-mid-market raise
Kartesia is relevant only at the very top of a £3–15m raise, and only for the more complex or growth-oriented situations. Its stated investment range starts around €10m and runs to ~€150m, so a sterling facility near the 12–15m ceiling — particularly a sponsorless founder/management business, a buy-and-build platform, or a situation needing structuring flexibility — is where it can be a credible counterparty. Its differentiator is the lower-mid-market sponsorless origination capability and the ability to flex from senior unitranche (KSO) into more opportunistic capital (KCO) on bespoke terms. For a borrower whose needs sit closer to €20–50m as the business grows, Kartesia scales with them.
Where they are not the fit
Below roughly £8–10m, Kartesia is structurally the wrong counterparty: the firm pioneered lower-mid-market lending in Europe but anchors its average cheque well above the £3–15m lower-mid-market range, and a vanilla £3–7m senior facility is too small to clear its process. It is not a fit for the simplest, most price-sensitive raises where a clearing bank or asset-based lender is cheaper and faster, nor for businesses that cannot support institutional private-credit pricing and documentation. As a fund manager rather than a balance-sheet bank, it does not offer transactional banking, working-capital lines or day-to-day operating facilities.
On the record
Kartesia manages roughly €7.5bn and describes itself as a privately owned, pan-European asset manager specialising in private corporate lending to lower-mid-market borrowers, pioneering lower-mid-market direct lending in Europe.
Kartesia runs four complementary strategies — Senior Direct Lending, Opportunistic/Credit Opportunities, an Article 9 Impact fund, and Structured Credit (CLOs) — and targets companies with enterprise values of roughly €30–250m.
The second-generation Kartesia Senior Opportunities (KSO) strategy raised €1.8bn (above a €1.5bn target), invests exclusively in 100% first-lien secured loans including unitranche, and targets European lower-mid-market companies.
New York Life Investments and its European affiliate Candriam took a majority stake in Kartesia, rising to about 80% from 33%.
New York Life Investments — strategic partnership announcement
Kartesia UK Ltd (company number 11924749) is an active private limited company incorporated 3 April 2019, registered at Interpark House, 7 Down Street, London W1J 7AJ, with SIC code 70221 (financial management).
Kartesia UK Ltd is authorised and regulated by the FCA (Firm Reference Number 920933), authorised from 5 August 2020.
FCA Financial Services Register — Kartesia UK Ltd (FRN 920933)
The earlier UK entity Kartesia Advisor LLP (OC385042), incorporated 10 May 2013, is dissolved.
This profile is a curated reference note drawn from public sources, not financial advice or a recommendation. Appetite and terms change; a lender's fit for a given credit is established by approaching it, not inferred from a page.